GENE ONLINE|News &
Opinion
Blog

Partnerships
ImmunoPrecise Antibodies, Libera Bio Ink $155 Million Pact To Deliver Antibodies With Nanotechnology
2023-03-16
Merck Strikes $50 Million Deal with ModeX For Rights to EBV Vaccine
2023-03-08
Moderna, Life Edit To Develop In Vivo Gene Editing Therapies
2023-02-23
Japan’s Gaia BioMedicine Teams Up With TreeFrog Therapeutics To Advance NK-Like Cell Therapies
2023-02-17
Replay And MD Anderson Launches Syena To Lead TCR-NK Cell Therapy
2023-02-15
FDA Clears Exelixis, Sairopa’s SIRPα Antibody For Solid Tumor Trial
2023-02-14
CARsgen Taps Huadong to Commercialize Multiple Myeloma CAR-T in China
2023-01-17
Bayer Signs Up To Google Cloud To Boost Drug Discovery
2023-01-13
JPM23: Partnerships Take off From JP Morgan Healthcare Conference 2023 Day One
2023-01-10
Antengene To Pair CD73 Inhibitor With Merck’s Keytruda In Clinical Collaboration
2022-12-27
Pfizer Begins Phase 2 Of Diabetes Drug, Triggering $10 Million Milestone To Sosei Heptares
2022-12-22
Jazz Opts Into License Zymeworks’ Solid Tumor Med With $325 Million Payment
2022-12-21
GSK Buys into Wave’s Oligonucleotide Program With $170 Million
2022-12-14
Kite And Arcellx Join Forces for Developing Cell Therapy targeting Multiple Myeloma
2022-12-12
Summit Bets $5 Billion On Akeso’s Bispecific Antibody
2022-12-07
1 2 3 4
LATEST
GSK Bets $593 Million To License Scynexis’ Oral Antifungal
2023-03-31
3D Printed Brain Model Could Aid in Neurosurgery
2023-03-31
Latest Study on Neuronal Gene Expression May Shed Light on the Memory Formation Process
2023-03-30
Emergent BioSolutions’ Over-The-Counter Naloxone Nasal Spray Receives FDA Greenlight
2023-03-30
Current Trends of iPSC Manufacturing and Clinical Applications – An Interview with Professor Xianmin Zeng
2023-03-29
U.S.-German Joint Discovery May Spark Breakthrough in Diabetes Research
2023-03-29
Merck Regains Worldwide Rights to BAVENCIO After Parting Ways with Pfizer
2023-03-29
Scroll to Top